Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U M Reali

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Melanoma Research|August 1, 1997
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expressionS Moretti, C Pinzi, E Berti, et al.
Melanoma Research|March 21, 1998
Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot studyU M Reali, L Martini, L Borgognoni, et al.
Melanoma Research|December 3, 2002
Microsatellite analysis in cutaneous malignant melanomaD Massi, I Sardi, C Urso, et al.
Melanoma Research|April 1, 1994
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2G Melioli, M Guastella, C Semino, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Melanoma Research|August 1, 1997
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expressionS Moretti, C Pinzi, E Berti, et al.
Melanoma Research|March 21, 1998
Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot studyU M Reali, L Martini, L Borgognoni, et al.
Melanoma Research|December 3, 2002
Microsatellite analysis in cutaneous malignant melanomaD Massi, I Sardi, C Urso, et al.
Melanoma Research|April 1, 1994
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2G Melioli, M Guastella, C Semino, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
Pageof 5